Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

HSA Approval

SUGAMMADEX KABI SOLUTION FOR INJECTION 100 MG/ML

Approval Number

SIN16988P

Drug Name

SUGAMMADEX KABI SOLUTION FOR INJECTION 100 MG/ML

Product Name

SUGAMMADEX KABI SOLUTION FOR INJECTION 100 MG/ML

Approval Date

April 19, 2024

Registrant

FRESENIUS KABI (SINGAPORE) PTE LTD

Regulatory Information

Registrant

FRESENIUS KABI (SINGAPORE) PTE LTD

Drug Type

Therapeutic

Forensic Classification

Prescription Only

Formulation Information

Dosage Form

INJECTION, SOLUTION

Route of Administration

INTRAVENOUS

Medical Information

ATC Code

V03AB35

ATC Item Name

sugammadex

Manufacturer Information

Pharmaceutical Manufacturer

FRESENIUS KABI (SINGAPORE) PTE LTD

Manufacturers

Labesfal - Laboratórios Almiro, S.A.

Active Ingredients

Ingredient Name

Sugammadex Sodium eqv Sugammadex

Strength

100 mg/ml

Drug MonographSugammadex

Documents

Package Inserts

Sugammadex Kabi Solution for Injection PI.pdf

Approved: April 19, 2024

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy